Literature DB >> 27479746

The bright side of dark matter: lncRNAs in cancer.

Joseph R Evans, Felix Y Feng, Arul M Chinnaiyan.   

Abstract

The traditional view of genome organization has been upended in the last decade with the discovery of vast amounts of non-protein-coding transcription. After initial concerns that this "dark matter" of the genome was transcriptional noise, it is apparent that a subset of these noncoding RNAs are functional. Long noncoding RNA (lncRNA) genes resemble protein-coding genes in several key aspects, and they have myriad molecular functions across many cellular pathways and processes, including oncogenic signaling. The number of lncRNA genes has recently been greatly expanded by our group to triple the number of protein-coding genes; therefore, lncRNAs are likely to play a role in many biological processes. Based on their large number and expression specificity in a variety of cancers, lncRNAs are likely to serve as the basis for many clinical applications in oncology.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27479746      PMCID: PMC4966302          DOI: 10.1172/JCI84421

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  100 in total

1.  Salivary lncRNA as a potential marker for oral squamous cell carcinoma diagnosis.

Authors:  Haikuo Tang; Zhiyuan Wu; Jianping Zhang; Bing Su
Journal:  Mol Med Rep       Date:  2012-12-28       Impact factor: 2.952

2.  A natural antisense transcript regulates Zeb2/Sip1 gene expression during Snail1-induced epithelial-mesenchymal transition.

Authors:  Manuel Beltran; Isabel Puig; Cristina Peña; José Miguel García; Ana Belén Alvarez; Raúl Peña; Félix Bonilla; Antonio García de Herreros
Journal:  Genes Dev       Date:  2008-03-15       Impact factor: 11.361

Review 3.  Telomeres-structure, function, and regulation.

Authors:  Weisi Lu; Yi Zhang; Dan Liu; Zhou Songyang; Ma Wan
Journal:  Exp Cell Res       Date:  2012-09-21       Impact factor: 3.905

4.  Safety and efficacy of RNAi therapy for transthyretin amyloidosis.

Authors:  Teresa Coelho; David Adams; Ana Silva; Pierre Lozeron; Philip N Hawkins; Timothy Mant; Javier Perez; Joseph Chiesa; Steve Warrington; Elizabeth Tranter; Malathy Munisamy; Rick Falzone; Jamie Harrop; Jeffrey Cehelsky; Brian R Bettencourt; Mary Geissler; James S Butler; Alfica Sehgal; Rachel E Meyers; Qingmin Chen; Todd Borland; Renta M Hutabarat; Valerie A Clausen; Rene Alvarez; Kevin Fitzgerald; Christina Gamba-Vitalo; Saraswathy V Nochur; Akshay K Vaishnaw; Dinah W Y Sah; Jared A Gollob; Ole B Suhr
Journal:  N Engl J Med       Date:  2013-08-29       Impact factor: 91.245

5.  The polymorphism rs944289 predisposes to papillary thyroid carcinoma through a large intergenic noncoding RNA gene of tumor suppressor type.

Authors:  Jaroslaw Jendrzejewski; Huiling He; Hanna S Radomska; Wei Li; Jerneja Tomsic; Sandya Liyanarachchi; Ramana V Davuluri; Rebecca Nagy; Albert de la Chapelle
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-14       Impact factor: 11.205

6.  Discovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomy.

Authors:  Nicholas Erho; Anamaria Crisan; Ismael A Vergara; Anirban P Mitra; Mercedeh Ghadessi; Christine Buerki; Eric J Bergstralh; Thomas Kollmeyer; Stephanie Fink; Zaid Haddad; Benedikt Zimmermann; Thomas Sierocinski; Karla V Ballman; Timothy J Triche; Peter C Black; R Jeffrey Karnes; George Klee; Elai Davicioni; Robert B Jenkins
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

7.  Diverse Phenotypes and Specific Transcription Patterns in Twenty Mouse Lines with Ablated LincRNAs.

Authors:  Ka-Man Venus Lai; Guochun Gong; Amanda Atanasio; José Rojas; Joseph Quispe; Julita Posca; Derek White; Mei Huang; Daria Fedorova; Craig Grant; Lawrence Miloscio; Gustavo Droguett; William T Poueymirou; Wojtek Auerbach; George D Yancopoulos; David Frendewey; John Rinn; David M Valenzuela
Journal:  PLoS One       Date:  2015-04-24       Impact factor: 3.240

8.  Genome-wide analysis of the human p53 transcriptional network unveils a lncRNA tumour suppressor signature.

Authors:  Yolanda Sánchez; Victor Segura; Oskar Marín-Béjar; Alejandro Athie; Francesco P Marchese; Jovanna González; Luis Bujanda; Shuling Guo; Ander Matheu; Maite Huarte
Journal:  Nat Commun       Date:  2014-12-19       Impact factor: 14.919

9.  Plasma HULC as a promising novel biomarker for the detection of hepatocellular carcinoma.

Authors:  Hui Xie; Hongwei Ma; Danqiu Zhou
Journal:  Biomed Res Int       Date:  2013-05-22       Impact factor: 3.411

10.  The IncRNAs PCGEM1 and PRNCR1 are not implicated in castration resistant prostate cancer.

Authors:  John R Prensner; Anirban Sahu; Matthew K Iyer; Rohit Malik; Benjamin Chandler; Irfan A Asangani; Anton Poliakov; Ismael A Vergara; Mohammed Alshalalfa; Robert B Jenkins; Elai Davicioni; Felix Y Feng; Arul M Chinnaiyan
Journal:  Oncotarget       Date:  2014-03-30
View more
  173 in total

Review 1.  The emerging role of lncRNAs in the regulation of cancer stem cells.

Authors:  Rosario Castro-Oropeza; Jorge Melendez-Zajgla; Vilma Maldonado; Karla Vazquez-Santillan
Journal:  Cell Oncol (Dordr)       Date:  2018-09-14       Impact factor: 6.730

2.  Long non-coding RNA NKILA serves as a biomarker in the early diagnosis and prognosis of patients with colorectal cancer.

Authors:  Peng Jiang; Xiaoting Han; Yingnan Zheng; Jianchao Sui; Weiping Bi
Journal:  Oncol Lett       Date:  2019-06-24       Impact factor: 2.967

Review 3.  Long noncoding RNAs as novel serum biomarkers for the diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis.

Authors:  C Zheng; H Hao; L Chen; J Shao
Journal:  Clin Transl Oncol       Date:  2017-02-10       Impact factor: 3.405

4.  Transcriptome-Wide Association Study Identifies Susceptibility Loci and Genes for Age at Natural Menopause.

Authors:  Jiajun Shi; Lang Wu; Bingshan Li; Yingchang Lu; Xingyi Guo; Qiuyin Cai; Jirong Long; Wanqing Wen; Wei Zheng; Xiao-Ou Shu
Journal:  Reprod Sci       Date:  2018-05-30       Impact factor: 3.060

Review 5.  Emerging roles of non-coding RNAs in the pathogenesis, diagnosis and prognosis of osteosarcoma.

Authors:  Chongchong Wang; Juehua Jing; Li Cheng
Journal:  Invest New Drugs       Date:  2018-08-06       Impact factor: 3.850

6.  IncRNA H19 promotes tongue squamous cell carcinoma progression through β-catenin/GSK3β/EMT signaling via association with EZH2.

Authors:  Da-Ming Zhang; Zhao-Yu Lin; Zhao-Hui Yang; You-Yuan Wang; Di Wan; Jiang-Long Zhong; Pei-Lin Zhuang; Zhi-Quan Huang; Bin Zhou; Wei-Liang Chen
Journal:  Am J Transl Res       Date:  2017-07-15       Impact factor: 4.060

7.  Long noncoding RNA LINC00978 promotes cancer growth and acts as a diagnostic biomarker in gastric cancer.

Authors:  Min Fu; Zhenhua Huang; Xueyan Zang; Lei Pan; Wei Liang; Jingyan Chen; Hui Qian; Wenrong Xu; Pengcheng Jiang; Xu Zhang
Journal:  Cell Prolif       Date:  2017-12-21       Impact factor: 6.831

8.  NEAT1 polyA-modulating antisense oligonucleotides reveal opposing functions for both long non-coding RNA isoforms in neuroblastoma.

Authors:  Alina Naveed; Jack A Cooper; Ruohan Li; Alysia Hubbard; Jingwei Chen; Tao Liu; Steve D Wilton; Sue Fletcher; Archa H Fox
Journal:  Cell Mol Life Sci       Date:  2020-09-10       Impact factor: 9.261

Review 9.  Roles of miRNA and lncRNA in triple-negative breast cancer.

Authors:  Juan Xu; Kang-Jing Wu; Qiao-Jun Jia; Xian-Feng Ding
Journal:  J Zhejiang Univ Sci B       Date:  2020 Sept.       Impact factor: 3.066

10.  Myc target gene, long intergenic noncoding RNA, Linc00176 in hepatocellular carcinoma regulates cell cycle and cell survival by titrating tumor suppressor microRNAs.

Authors:  D D H Tran; C Kessler; S E Niehus; M Mahnkopf; A Koch; T Tamura
Journal:  Oncogene       Date:  2017-09-04       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.